Impact of Remote Monitoring on Long‐Term Prognosis in Heart Failure Patients in a Real‐World Cohort: Results From All‐Comers COMMIT‐HF Trial
The In‐TIME study revealed that multiparameter telemonitoring significantly improves clinical outcomes in patients with HF, with a reduction of 1‐year mortality.6 Similar data come from the EFFECT study, which showed a significant reduction in 1‐year mortality in an RM group (5% vs. 7%, in the favor of RM group).9 However, as stated by the authors, information system differences as well as the fact that devices were provided by a single manufacturer were obvious limitations to both studies. Moreover, those findings were based on control trials and do not fully reflect a real‐world experience.
There is still a paucity of data regarding the impact of RM on long‐term prognosis in patients derived from all‐comers registries equipped with systems produced by different manufacturers. Therefore, this study aimed to analyze the impact of RM on mortality and hospitalization rate using an all‐comers prospective observational registry from a high‐volume cardiovascular center.